![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
CLOTRIMAZOLE: A REVIEW OF ITS STRUCTURE, THERAPEUTIC CLASS AND PHARMACEUTICAL PROPERTIES, PHARMACEUTICAL DOSAGE FORMS AND ADMINISTRATION AND ANALYTICAL STUDY
Suneel Kumar*, Dr. Rizwana Khan and Dr. Bhawna Sharma
ABSTRACT Clotrimazole is currently a field of intensive research for the continued development of pharmaceuticals. There is an opportunity for new indications to be exploited and new formulations to be developed. New drugs such as posaconazole can replace clotrimazol in select, highly invasive fungal infections. The drug has been found to inhibit oral candidiasis for up to 6 hours and thermosensitive formulation of vaginal gel formed by the complexation of beta cyclodextrin clotrimrazole. The use of clotrimazole as the principal compound for design studies in structural preparations is being developed as a pharmaceuit to identify novel clinical indicators of treatment and to improve the administration of manufactured goods. The aim is to identify new clinical indicators that could be used to improve Manufacturing of medicines and pharmaceuticals. Keywords: . [Download Article] [Download Certifiate] |